Clinical outcomes of ibrutinib in patients with relapsed or refractory mantle cell lymphoma: Korean multicenter, retrospective analysis

$Clinical outcomes of ibrutinib in patients with relapsed or refractory mantle cell lymphoma: Korean multicenter, retrospective analysis$

Journal article

Open access

Peer reviewed

J.H. Yi, W.S. Kim, S.J. Kim, D.H. Yoon, C. Suh, M.H. Chang, D.H. Yang, J.-C. Jo, S.Y. Hyun, H.-S. Eom, …

Annals of oncology, Vol.30, p.ix193

11/2019

Files and links (1)

url

https://doi.org/10.1093/annonc/mdz446.012View

Published (Version of record) Open

1 Record Views

Title: Clinical outcomes of ibrutinib in patients with relapsed or refractory mantle cell lymphoma: Korean multicenter, retrospective analysis
Creators - without role: J.H. Yi - Chung-Ang University Hospital
W.S. Kim - Samsung Medical Center
S.J. Kim - Samsung Medical Center
D.H. Yoon - University of Ulsan
C. Suh - Ulsan College
M.H. Chang - National Health Insurance Service Ilsan Hospital
D.H. Yang - Chonnam National University Hwasun Hospital
J.-C. Jo - Ulsan University Hospital
S.Y. Hyun - Yonsei University
H.-S. Eom - National Cancer Center
J.-O. Lee - Seoul National University Bundang Hospital
J.H. Kwon - Chungbuk National University Hospital
S.H. Han - Jeju National University Hospital
S.-S. Lee - Wonkwang University
J.-Y. Kwak - Jeonbuk National University
S.H. Kim - Soonchunhyang University
Publication Details: Annals of oncology, Vol.30, p.ix193
Identifiers: 9941594708331
Academic Unit: King Abdullah University of Science & Technology
Language: English
Resource Type: Journal article